| Autor: |
Pan E; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Shaya J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Madlensky L; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Randall JM; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Javier-Desloges J; Department of Urology, University of California San Diego, La Jolla, CA, USA., Millard FE; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Rose B; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA., Parsons JK; Department of Urology, University of California San Diego, La Jolla, CA, USA., Nielsen SM; Invitae Corporation, San Francisco, CA, USA., Hatchell KE; Invitae Corporation, San Francisco, CA, USA., Esplin ED; Invitae Corporation, San Francisco, CA, USA., Nussbaum RL; Invitae Corporation, San Francisco, CA, USA., Weise N; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Murphy J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Martinez ME; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., McKay RR; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA. rmckay@health.ucsd.edu. |
Full text from SpringerLink